课题基金 / 基金详情

Prize 202209PJT - Early Career Award in Cancer: An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial

Prize 202209PJT - Early Career Award in Cancer: An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial
奖 202209PJT - 癌症早期职业奖：食管鳞状细胞癌新辅助放化疗与根治性放化疗（根据需要进行挽救手术）的国际随机试验 - NEEDS 试验
批准号：
477684
负责人：
Lukovic Jelena
金额：
$1.82万
依托单位：
Princess Margaret Cancer Centre (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-09-01 至 2023-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=477684&lang=en
关键词：
Esophagectomy Radiotherapy Randomized Trial Squamous Cell Carcinoma Esophagus

项目摘要

项目成果

Lukovic Jelena的其他基金

相似基金

相关文献

中文摘要
翻译
食道癌是全球第六大癌症死亡原因。食道鳞状细胞癌(ESCC)占全球病例的90%，其根治性治疗方法存在争议。接受手术的候选人最好用放化疗。
英文摘要
Esophageal cancer is the 6th leading cause of cancer death worldwide. Curative treatment for esophageal squamous cell carcinoma (ESCC), representing 90% of cases globally, is controversial. Candidates for surgery are preferably treated with chemoradiother
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金